Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Beta-blocker benefit in atherosclerosis?

Giving a beta-blocker may help to slow progression of atherosclerosis, according to Swedish research. 

Dr G. Bondjers (University of Gothenburg) reported a study that was carried out to investigate whether treatment with metoprolol could affect subclinical atherosclerosis in patients with hypercholesterolaemia receiving lipid lowering drugs. He said that beta-blockers were known to reduce reinfarction after myocardial infarction and to reduce the risk of coronary events in hypertension. Several animal studies had indicated a positive effect on atheroscelerosis, but there had been no previous studies of their clinical effect.

His study, which included researchers from Astra Zeneca, involved patients with primary hypercholesterolaemia (cholesterol above 6.5) and subclinical atherosclerosis, identified as a maximum intima-media thickness of >1.0mm and/or a measurable plaque in the carotid artery.

Seventy-nine patients (35 on metoprolol 100mg and 44 on placebo) completed the study, with a three-year mean follow up. Hypercholesterolaemia was treated as normal, generally with a statin.

Dr Bondjers reported that the intima-media thickness of the common carotid artery decreased in the beta-blocker group and increased in the placebo group.

Although this was only preliminary data, it could indicate that beta-blockers had a favourable effect on atherosclerosis, he said.

Citation: The Pharmaceutical Journal URI: 20002119

Rate this article 

Click to rate

  • 1 star out of 5
  • 2 stars out of 5
  • 3 stars out of 5
  • 4 stars out of 5
  • 5 stars out of 5

0 out of 5 stars

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Rate
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Similar topics

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.